These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37110811)

  • 1. Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion.
    D'yachenko V; Danilov D; Kuznetsov Y; Moiseev S; Mokhov V; Burmistrov V; Butov G
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroaromatic fragments on 1,3-disubstituted ureas enhance soluble epoxide hydrolase inhibition.
    Burmistrov V; Morisseau C; D'yachenko V; Rybakov VB; Butov GM; Hammock BD
    J Fluor Chem; 2019 Apr; 220():48-53. PubMed ID: 32132741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors.
    Burmistrov VV; Morisseau C; Shkineva TK; Danilov DV; Gladkikh B; Butov GM; Fayzullin RR; Dutova TY; Hammock BD; Dalinger IL
    J Fluor Chem; 2023 Feb; 266():. PubMed ID: 37638129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy.
    Burmistrov VV; Morisseau C; Danilov DV; Gladkikh BP; D'yachenko VS; Zefirov NA; Zefirova ON; Butov GM; Hammock BD
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2274797. PubMed ID: 37975322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.
    Burmistrov V; Morisseau C; Harris TR; Butov G; Hammock BD
    Bioorg Chem; 2018 Feb; 76():510-527. PubMed ID: 29310082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.
    Scherman MS; North EJ; Jones V; Hess TN; Grzegorzewicz AE; Kasagami T; Kim IH; Merzlikin O; Lenaerts AJ; Lee RE; Jackson M; Morisseau C; McNeil MR
    Bioorg Med Chem; 2012 May; 20(10):3255-62. PubMed ID: 22522007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally bioavailable potent soluble epoxide hydrolase inhibitors.
    Hwang SH; Tsai HJ; Liu JY; Morisseau C; Hammock BD
    J Med Chem; 2007 Aug; 50(16):3825-40. PubMed ID: 17616115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Karlov D; Pitushkin D; Vernigora A; Rasskazova E; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127430. PubMed ID: 32736212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
    Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD
    Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.
    Rose TE; Morisseau C; Liu JY; Inceoglu B; Jones PD; Sanborn JR; Hammock BD
    J Med Chem; 2010 Oct; 53(19):7067-75. PubMed ID: 20812725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
    Hwang SH; Morisseau C; Do Z; Hammock BD
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.
    Kim IH; Tsai HJ; Nishi K; Kasagami T; Morisseau C; Hammock BD
    J Med Chem; 2007 Oct; 50(21):5217-26. PubMed ID: 17894481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase.
    Huang SX; Cao B; Morisseau C; Jin Y; Hammock BD; Long YQ
    Medchemcomm; 2012 Mar; (3):379-384. PubMed ID: 25225606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
    Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
    Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety.
    Burmistrov V; Morisseau C; Babkov DA; Golubeva T; Pitushkin D; Sokolova EV; Vasipov V; Kuznetsov Y; Bazhenov SV; Novoyatlova US; Bondarev NA; Manukhov IV; Osipova V; Berberova N; Spasov AA; Butov GM; Hammock BD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
    Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
    Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.